Recent U.S. Court Decisions for Valid Priority Claims AIPLA AIPLA Mid-Winter Institute IP Practice in Japan Committee Pre-Meeting Seminar January 29-30,

Slides:



Advertisements
Similar presentations
TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
Advertisements

Feichter_DPG-SYKL03_Bild-01. Feichter_DPG-SYKL03_Bild-02.
1 Practical Impact of Recent PCT Changes on US Practice Maria Eliseeva Houston Eliseeva LLP American Intellectual Property Law Association October 15,
Copyright © 2003 Pearson Education, Inc. Slide 1 Computer Systems Organization & Architecture Chapters 8-12 John D. Carpinelli.
Chapter 1 The Study of Body Function Image PowerPoint
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 6 Author: Julia Richards and R. Scott Hawley.
Author: Julia Richards and R. Scott Hawley
1 Copyright © 2013 Elsevier Inc. All rights reserved. Appendix 01.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 38.
1 Chapter 40 - Physiology and Pathophysiology of Diuretic Action Copyright © 2013 Elsevier Inc. All rights reserved.
Properties Use, share, or modify this drill on mathematic properties. There is too much material for a single class, so you’ll have to select for your.
UNITED NATIONS Shipment Details Report – January 2006.
and 6.855J Spanning Tree Algorithms. 2 The Greedy Algorithm in Action
1 RA I Sub-Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Casablanca, Morocco, 20 – 22 December 2005 Status of observing programmes in RA I.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Exit a Customer Chapter 8. Exit a Customer 8-2 Objectives Perform exit summary process consisting of the following steps: Review service records Close.
0 - 0.
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
FACTORING ax2 + bx + c Think “unfoil” Work down, Show all steps.
Addition Facts
ZMQS ZMQS
REVIEW: Arthropod ID. 1. Name the subphylum. 2. Name the subphylum. 3. Name the order.
Break Time Remaining 10:00.
EU Market Situation for Eggs and Poultry Management Committee 21 June 2012.
2 |SharePoint Saturday New York City
© S Haughton more than 3?
VOORBLAD.
15. Oktober Oktober Oktober 2012.
William Boshnick Greenblum & Bernstein, P.L.C.
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
 1 IP High Court Case Review Finding of Invention Disclosed in Cited Prior Art in Finding Non-Inventive Step Pre-Meeting AIPLA Mid-Winter Meeting January.
1 RA III - Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Buenos Aires, Argentina, 25 – 27 October 2006 Status of observing programmes in RA.
Factor P 16 8(8-5ab) 4(d² + 4) 3rs(2r – s) 15cd(1 + 2cd) 8(4a² + 3b²)
Basel-ICU-Journal Challenge18/20/ Basel-ICU-Journal Challenge8/20/2014.
1..
© 2012 National Heart Foundation of Australia. Slide 2.
LO: Count up to 100 objects by grouping them and counting in 5s 10s and 2s. Mrs Criddle: Westfield Middle School.
Understanding Generalist Practice, 5e, Kirst-Ashman/Hull
Chapter 5 Test Review Sections 5-1 through 5-4.
1 First EMRAS II Technical Meeting IAEA Headquarters, Vienna, 19–23 January 2009.
Benjamin Banneker Charter Academy of Technology Making AYP Benjamin Banneker Charter Academy of Technology Making AYP.
Addition 1’s to 20.
25 seconds left…...
Incorporation by Reference
H to shape fully developed personality to shape fully developed personality for successful application in life for successful.
Januar MDMDFSSMDMDFSSS
Week 1.
Analyzing Genes and Genomes
We will resume in: 25 Minutes.
©Brooks/Cole, 2001 Chapter 12 Derived Types-- Enumerated, Structure and Union.
Essential Cell Biology
Clock will move after 1 minute
Intracellular Compartments and Transport
PSSA Preparation.
Essential Cell Biology
Weekly Attendance by Class w/e 6 th September 2013.
1 PART 1 ILLUSTRATION OF DOCUMENTS  Brief introduction to the documents contained in the envelope  Detailed clarification of the documents content.
Energy Generation in Mitochondria and Chlorplasts
Murach’s OS/390 and z/OS JCLChapter 16, Slide 1 © 2002, Mike Murach & Associates, Inc.
CpSc 3220 Designing a Database
Presentation transcript:

Recent U.S. Court Decisions for Valid Priority Claims AIPLA AIPLA Mid-Winter Institute IP Practice in Japan Committee Pre-Meeting Seminar January 29-30, 2013 Raymond E. Farrell Carter, DeLuca, Farrell & Schmidt, LLP

Right of Priority/ Benefit of Earlier Filing Date in the U.S. Domestic – 35 U.S.C. § 120 Foreign – 35 U.S.C. § 119(a-d) Provisional Appln. – 35 U.S.C. § 119(e) 2

Domestic Priority - 35 U.S.C. 120 Adequate Disclosure Common Inventor Co-pendency Specific Reference to Earlier Application(s) 3

Foreign Priority - 35 U.S.C. 119 (a-d) Nexus of Applicants Same Invention Claim to Priority Filed in the USPTO Certified Copy of Priority Document Filed Within 12 Months 4

Provisional App Priority - 35 U.S.C. 119(e) Adequate Disclosure Common Inventor Filed Within 12 Months Specific Reference to Provisional Application(s) 5

Adequate Disclosure Santarus v. Par Pharmaceutical (Fed. Cir. 2012) negative claim limitations are adequately supported when the specification describes a reason to exclude the relevant limitation Express disclaimer of the limitation is not required for support listing disadvantages is sufficient 6

Santarus Claim 1 1. A method for treating an acid-caused gastrointestinal disorder comprising the step of administering to a subject suffering from said disorder a solid pharmaceutical composition comprising: (a) about 10 mg to about 40 mg of …; and (b) sodium bicarbonate in an amount of …; wherein the composition contains no sucralfate, …. 7

Santarus Specification “The only patient whose death was attributed to stress- related upper gastrointestinal bleeding was in the sucralfate arm.” (Summary) “H2-antagonists, antacids, and sucralfate … have certain disadvantages associated with their use....” (Detailed Description) 8

Adequate Disclosure Hollmer v. Harari (Fed. Cir. 2012) Incorporation by reference statement at the initial filing stage - identity of the incorporated reference is clear to a reasonable examiner in light of the documents presented (Harari 1) Incorporation by reference statement in intermediate applications - must identify with detailed particularity what specific material is incorporated to a person of ordinary skill (Harari 2) 9

Nexus Boston Scientific v. Medtronic (Fed. Cir. 2007) Foreign application may only form the basis for priority under §119(a) if that application was filed by either the U.S. Applicant or by someone acting on behalf of the U.S. Applicant Nexus required between the U.S. Applicant and any entity acting on behalf of the U.S. Applicant at the time of the filing of the foreign priority case 10

Cragg ‘402 (Boston Scientific) 8/19/94 Martin ‘817 Fogarty ‘836 (Medtronic) MinTec French app US ‘681 App 4/23/98 2/9/94 6/5/95 6/8/94 11 Boston Scientific v. Medtronic

Specific Reference to Earlier Applications Encyclopaedia Britannica v. Alpine Elect. (Fed. Cir. 2010) priority claim is invalid where an intermediate application fails to satisfy the requirements under 35 U.S.C. §120 amendments in later applications cannot cure an otherwise defective priority claim in an earlier application in the priority chain 12

10/29/89 ‘917 app ‘955 app ‘985 app ‘814 app ‘812 app ‘494 app 8/31/93 2/28/94 3/23/953/25/02 4/8/03 6/13/05 12/20/05 Encyclopaedia Britannica v. Alpine Elect. 13

THANK YOU! 14

References In re Gosteli, 872 F.2d 1008 (Fed. Cir. 1989) (Foreign application must be examined to ascertain if it supports, within the meaning of §112 ¶1, what is claimed in the U.S. application.) Santarus, Inc. v. Par Pharmaceutical, Inc., 694 F.3d 1344 (Fed. Cir. 2012) Hollmer v. Harari, 681 F.3d 1351 (Fed. Cir. 2012) Boston Scientific Scimed, Inc. v. Medtronic Vascular, Inc., 497 F.3d 1293 (Fed. Cir. 2007) Encyclopaedia Britannica, Inc. v. Alpine Electronics of America, Inc., 609 F.3d 1345 (Fed. Cir. 2010) 15

16 35 U.S.C. § 120 (AIA effective 3/16/13)

17 Changes to 35 U.S.C. § 119(a) (AIA effective 3/16/13)

18 Changes to 35 U.S.C. § 119(e) (AIA effective 3/16/13)